Office of the Revisor of Statutes

SF 131

Status in the Senate - 92nd Legislature (2021 - 2022)

Current bill text: As Introduced
Add SF131 to MyBills
Version List

Companion: HF58
Companion Text
House Search

Revisor number: 21-01238

Long Description

Committee Hearings and Actions

Senate Counsel & Research Summary
Fiscal Notes

Engrossments
Introduction PDF	Posted on 01/13/2021

Description

Drug manufacturers requirement to report and maintain prescription drug prices authorization; prescription drug formularies filing requirement; health carriers denying or limiting coverage due to lack of prior authorization prohibition; prescription benefit tool requirements establishment; prescription drug benefit transparency and disclosure requirement

Authors (3)

Actions

Senate

01/14/2021	Introduction and first reading pg. 101 Intro
01/14/2021	Referred to Health and Human Services Finance and Policy
03/09/2022	Author added Putnam pg. 5263
03/28/2022	Author added Nelson pg. 5659

Senate Actions	House Actions
01/14/2021
Introduction and first reading pg. 101 Intro Referred to Health and Human Services Finance and Policy
03/09/2022
Author added Putnam pg. 5263
03/28/2022
Author added Nelson pg. 5659